Cnsp stock news
WebMar 29, 2024 · CNS Pharmaceuticals Announces Reverse Stock Split. CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-30 reverse. … WebMar 10, 2024 · Compare with up to 5 Stocks On Friday 03/10/2024 the closing price of the CNS Pharmaceuticals Inc Registered Shs share was $1.26 on NAS. Compared to the …
Cnsp stock news
Did you know?
WebCNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and … WebCNS Pharmaceuticals, Inc. (CNSP) NasdaqCM - NasdaqCM Delayed Price. Currency in USD Follow 2W 10W 9M 1.1400 +0.0900 (+8.57%) At close: 03:57PM EDT Summary Company Insights Chart Conversations...
WebApr 6, 2024 · NASDAQ:CNSP CNS Pharmaceuticals - CNSP Price Target & Analyst Ratings $0.75 -0.12 (-13.79%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $0.70 $1.41 50-Day Range $0.75 $2.45 52-Week Range $0.70 $13.43 Volume 12.52 million shs Average Volume 236,845 shs Market Capitalization $10.01 million P/E Ratio N/A … WebGet the latest CNS Pharmaceuticals Inc (CNSP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …
WebApr 6, 2024 · The MarketWatch News Department was not involved in the creation of this content. Apr 06, 2024 (Investor Brand Network via COMTEX) -- CNS Pharmaceuticals (NASDAQ: CNSP) today announced its receipt ... WebJul 9, 2024 · News for CNS Pharmaceuticals Stock (CNSP) CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Outlook. PRNewsWire • …
WebView the latest CNS Pharmaceuticals Inc. (CNSP) stock price, news, historical charts, analyst ratings and financial information from WSJ. CNSP CNS Pharmaceuticals Inc. …
WebThe bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CNSP as an investment opportunity. In terms of how CNS PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 47.72% of that group. inaturalist michiganWebAbout CNS Pharmaceuticals (CNSP) CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by … inaturalist ncWebFind the latest news headlines from CNS Pharmaceuticals, Inc. Common Stock (CNSP) at Nasdaq.com. inaturalist merchWebMar 30, 2024 · CNSP News Today Why did CNS Pharmaceuticals stock go up today? NASDAQ:CNSP CNS Pharmaceuticals - CNSP News Today $1.72 +0.06 (+3.61%) (As of 03/3/2024 12:00 AM ET) Compare Today's Range $1.60 $1.78 50-Day Range $1.59 $3.08 52-Week Range $1.55 $13.43 Volume 30,799 shs Average Volume 44,983 shs Market … inaturalist how to useWebCNSP News Highlights. For CNSP, its 30 day story count is now at 3. Over the past 20 days, the trend for CNSP's stories per day has been choppy and unclear. It has … inaturalist marble bowlWebApr 5, 2024 · A high-level overview of CNS Pharmaceuticals, Inc. (CNSP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … inches of shoe sizesWebStock analysis for CNS Pharmaceuticals Inc (CNSP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. inaturalist map the mistletoe